HeartSciences Inc. will hold its annual meeting virtually via a live audio webcast on April 30, 2026. Shareholders will vote on the election of one Class III director, with Andrew Simpson nominated. They will also vote on increasing the number of shares reserved for issuance under the company’s 2023 Equity Incentive Plan to 1.25 million shares plus evergreen shares. Additional proposals include amending the company’s certificate of formation to provide officer exculpation and ratifying Haskell & White LLP as the independent auditor for the fiscal year ending April 30, 2026. Shareholders will also vote on a proposal to allow adjournment of the meeting if needed to solicit additional proxies.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-024792), on March 06, 2026, and is solely responsible for the information contained therein.
Comments